Sharon J. Sha

2.4k total citations
19 papers, 1.0k citations indexed

About

Sharon J. Sha is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Sharon J. Sha has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 8 papers in Physiology and 5 papers in Psychiatry and Mental health. Recurrent topics in Sharon J. Sha's work include Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (5 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Sharon J. Sha is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (5 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Sharon J. Sha collaborates with scholars based in United States, Italy and Ethiopia. Sharon J. Sha's co-authors include Bruce L. Miller, Howard J. Rosen, Joel H. Kramer, Kate Rankin, Julene K. Johnson, Leonel Tadao Takada, Athanasia Boumis, Elizabeth C. Mormino, Kathleen L. Poston and Enhao Gong and has published in prestigious journals such as Neurology, Annals of Neurology and Radiology.

In The Last Decade

Sharon J. Sha

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon J. Sha United States 11 356 329 317 271 212 19 1.0k
Edoardo Gioele Spinelli Italy 22 300 0.8× 792 2.4× 396 1.2× 381 1.4× 239 1.1× 58 1.5k
Catherine F. Slattery United Kingdom 20 373 1.0× 169 0.5× 349 1.1× 303 1.1× 254 1.2× 39 1.1k
R. Allom United Kingdom 9 298 0.8× 157 0.5× 175 0.6× 428 1.6× 434 2.0× 15 1.3k
Chenjie Xia United States 12 331 0.9× 197 0.6× 231 0.7× 382 1.4× 87 0.4× 24 920
Francesca Caso Italy 20 457 1.3× 452 1.4× 397 1.3× 611 2.3× 345 1.6× 65 1.3k
De Cristofaro Italy 15 345 1.0× 289 0.9× 323 1.0× 278 1.0× 216 1.0× 44 1.0k
Maura Cosseddu Italy 23 380 1.1× 659 2.0× 424 1.3× 516 1.9× 152 0.7× 58 1.4k
Teresa Moreno‐Ramos Spain 25 575 1.6× 261 0.8× 347 1.1× 470 1.7× 167 0.8× 52 1.3k
Daniel Bittner Germany 22 310 0.9× 531 1.6× 372 1.2× 233 0.9× 100 0.5× 39 1.2k
Éloi Magnin France 18 413 1.2× 266 0.8× 197 0.6× 300 1.1× 55 0.3× 89 1.0k

Countries citing papers authored by Sharon J. Sha

Since Specialization
Citations

This map shows the geographic impact of Sharon J. Sha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon J. Sha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon J. Sha more than expected).

Fields of papers citing papers by Sharon J. Sha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon J. Sha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon J. Sha. The network helps show where Sharon J. Sha may publish in the future.

Co-authorship network of co-authors of Sharon J. Sha

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon J. Sha. A scholar is included among the top collaborators of Sharon J. Sha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon J. Sha. Sharon J. Sha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Greeley, David, Marshall Nash, Niels D. Prins, et al.. (2025). A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer’s disease. The Journal of Prevention of Alzheimer s Disease. 12(9). 100337–100337.
2.
Young, Christina B., Joseph R. Winer, Kyan Younes, et al.. (2024). Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation. Alzheimer s & Dementia. 20(8). 5299–5310. 6 indexed citations
3.
Rutledge, Jarod, Patricia Moran‐Losada, Michaël E. Belloy, et al.. (2023). Post‐translational modifications linked to preclinical Alzheimer's disease–related pathological and cognitive changes. Alzheimer s & Dementia. 20(3). 1851–1867. 3 indexed citations
4.
Sha, Sharon J., et al.. (2023). Lewy Body Dementia: An Overview of Promising Therapeutics. Current Neurology and Neuroscience Reports. 23(10). 581–592. 3 indexed citations
5.
Shahid, Marian, Veronica Ramirez, Sephira G. Ryman, et al.. (2022). Illusory Responses across the Lewy Body Disease Spectrum. Annals of Neurology. 93(4). 702–714. 8 indexed citations
6.
Mormino, Elizabeth C., et al.. (2021). Six Recurrent Amyloid-Related Imaging Abnormality Episodes in a Patient Treated With Aducanumab. JAMA Neurology. 79(1). 87–87. 4 indexed citations
7.
Cotter, Kristina, Carly E. Siskind, Sharon J. Sha, & Andrea Hanson‐Kahn. (2019). Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington’s Disease Community. Journal of Huntington s Disease. 8(4). 421–430. 12 indexed citations
8.
Chen, Kevin T., Enhao Gong, Fabíola Macruz, et al.. (2018). Ultra–Low-Dose18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs. Radiology. 290(3). 649–656. 182 indexed citations
9.
Sha, Sharon J., Gayle K. Deutsch, Lü Tian, et al.. (2018). Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study. JAMA Neurology. 76(1). 35–35. 92 indexed citations
10.
Possin, Katherine L., Hosung Kim, Michael D. Geschwind, et al.. (2017). Egocentric and allocentric visuospatial working memory in premotor Huntington's disease: A double dissociation with caudate and hippocampal volumes. Neuropsychologia. 101. 57–64. 15 indexed citations
11.
Block, Nikolas, Sharon J. Sha, Anna M. Karydas, et al.. (2015). Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers. American Journal of Geriatric Psychiatry. 24(2). 107–116. 24 indexed citations
12.
Sha, Sharon J., Pia Ghosh, Suzee E. Lee, et al.. (2015). Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Alzheimer s Research & Therapy. 7(1). 8–8. 31 indexed citations
13.
Sha, Sharon J., Anna M. Khazenzon, Pia Ghosh, et al.. (2015). Early-onset Alzheimer’s disease versus frontotemporal dementia: resolution with genetic diagnoses?. Neurocase. 22(2). 161–167. 3 indexed citations
14.
Geschwind, Michael D., Sharon J. Sha, Alexandra C. Apple, et al.. (2013). Executive functions in premanifest Huntington's disease. Movement Disorders. 29(3). 405–409. 49 indexed citations
15.
Sha, Sharon J. & Adam L. Boxer. (2012). Treatment implications of C9ORF72. Alzheimer s Research & Therapy. 4(6). 46–46. 8 indexed citations
16.
Takada, Leonel Tadao & Sharon J. Sha. (2012). Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease. Alzheimer s Research & Therapy. 4(5). 38–38. 30 indexed citations
17.
Sha, Sharon J., Leonel Tadao Takada, Katherine P. Rankin, et al.. (2012). Frontotemporal dementia due toC9ORF72mutations. Neurology. 79(10). 1002–1011. 147 indexed citations
18.
Sha, Sharon J. & Robert B. Layzer. (2007). Myasthenia gravis and Lambert–Eaton myasthenic syndrome in the same patient. Muscle & Nerve. 36(1). 115–117. 12 indexed citations
19.
Kramer, Joel H., Sharon J. Sha, Kate Rankin, et al.. (2003). Distinctive Neuropsychological Patterns in Frontotemporal Dementia, Semantic Dementia, And Alzheimer Disease. Cognitive and Behavioral Neurology. 16(4). 211–218. 393 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edoardo Gioele Spinelli Breakdown of academic impact, for papers by Catherine F. Slattery Breakdown of academic impact, for papers by R. Allom Breakdown of academic impact, for papers by Chenjie Xia Breakdown of academic impact, for papers by Francesca Caso Breakdown of academic impact, for papers by De Cristofaro Breakdown of academic impact, for papers by Maura Cosseddu Breakdown of academic impact, for papers by Teresa Moreno‐Ramos Breakdown of academic impact, for papers by Daniel Bittner Breakdown of academic impact, for papers by Éloi Magnin
Rankless by CCL
2026